Clinical Immunology 188 (2018) 81–84 Contents lists available at ScienceDirect Clinical Immunology journal homepage: www.elsevier.com/locate/yclim Reduced frequency of peripheral CD4 + CD45RA + CD31+ cells and autoimmunity phenomena in patients affected by Del22q11 syndrome a, b a a a c Silvia Ricci , Marzio Masini , Claudia Valleriani , Arianna Casini , Martina Cortimiglia , Laura Grisotto , a d a a Clementina Canessa ,GiuseppeIndolﬁ , Francesca Lippi , Chiara Azzari Division of Immunology, Section of Pediatrics, Department of Health Sciences, University of Florence and Anna Meyer Children's Hospital, Florence,Italy Pediatric Division, Sapienza University, Rome, Italy Department of Statistics, Informatics and Applications "G. Parenti", University of Florence, Florence, Italy Pediatric Division, Anna Meyer Children's Hospital, Florence, Italy article i nfo developing severe infections and/or autoimmune manifestations in pa- tients with Del22q11 syndrome . CD4 + CD45RA + CD31+ cells or Article history: recent thymic emigrants (RTEs) are lymphocytes that have only recent- Received 20 October 2017 Received in revised form 22 November 2017 ly left the thymus and have not undergone further proliferation (as doc- accepted with revision 23 December 2017 umented by high TREC concentrations) and antigen selection. Previous Available online 29 December 2017 studies have suggested an
Clinical Immunology – Elsevier
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera